Nine months ended 30 Sep
Key Consolidated Statement of Comprehensive Income Items	2021 US$ mn (unaudited)	2020 US$ mn (restated) (unaudited)
Revenue	3,305	3,200
Gross Profit	645	994
Share of Profit/(Loss) of a 35%-owned Associate - CTI	(64)	-
Profit/(Loss) Attributable to Shareholders	(17)	496
Profit Attributable to Shareholders before Biological Assets Fair Value Changes	110	502
	As at 30 Sep 2021	As at 31 Dec 2020
Key Consolidated Statement of Financial Position Items	(unaudited) US$ mn	(audited) US$ mn
Property, Plant & Equipment	1,684	1,589
Investment in Associates	2,185	2,331
Total Assets	6,613	6,597
Bank and Other Borrowings	1,384	1,136
Issued Capital	253	253
Shareholders' Equity	3,248	3,548
Total Equity	3,597	4,033